Pharmacological Characterization of the Nociceptin/Orphanin FQ Receptor Antagonist SB-612111 [(–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5 H-benzocyclohepten-5-ol]: In Vivo Studies
Anna Rizzi(University of Ferrara), Girolamo Calò(University of Padua), Roberto Ciccocioppo(Università di Camerino), Silvia Zucchini(University of Ferrara), D. Regoli(University of Ferrara), Giuliano Marzola(University of Ferrara), Claudio Trapella(University of Ferrara), Elaine C. Gavioli(University of Ferrara), Barbara Spagnolo(University of Salento)
Cited by 77
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization
|Trends in Pharmacological Sciences|1988|358